Anastasia Khvorova
Founder at Advirna LLC
Anastasia Khvorova active positions
Companies | Position | Start | End |
---|---|---|---|
Advirna LLC
Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Founder | 01/01/2007 | - |
Corporate Officer/Principal | 01/01/2007 | - |
Career history of Anastasia Khvorova
Former positions of Anastasia Khvorova
Companies | Position | Start | End |
---|---|---|---|
PHIO PHARMACEUTICALS CORP. | Chief Tech/Sci/R&D Officer | - | 27/04/2012 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Chief Tech/Sci/R&D Officer | 01/10/2008 | 24/09/2011 |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Founder | - | - |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Director/Board Member | - | - |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Chief Tech/Sci/R&D Officer | 07/07/2009 | - |
Corporate Officer/Principal | 01/09/2002 | 07/07/2009 |
Training of Anastasia Khvorova
Russian Academy of Sciences | Doctorate Degree |
Statistics
International
United States | 7 |
Russia | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Founder | 2 |
Sectoral
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Private companies | 5 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO. | Commercial Services |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
Advirna LLC
Advirna LLC BiotechnologyHealth Technology Advirna LLC engages in the development of new nucleic-based technologies for therapeutic and research use. It offers validated self-deliverable ribonucleic acid (SDRNA), in vivo SDRNA, transfection controls, starter kits, and custom SDRNA. The company was founded by Anastasia Khvorova and Alexey Wolfson in 2007 and is headquartered in Worcester, MA. | Health Technology |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
- Stock Market
- Insiders
- Anastasia Khvorova
- Experience